Home LiteratureArticle Details
PMID: 1965794 Published · ppublish English Journal Article Review

Type IV collagenases in tumor invasion and metastasis.

Cancer metastasis reviews ·Vol. 9 ·No. 4 ·1990-12-00 ·Pages 289-303

Stetler-Stevenson WG

Abstract

The invasion and metastasis of cancer cells is a complex multistep process involving destruction of basement membranes as an early event in the metastatic cascade. Recent evidence implicates secreted matrix metalloproteinase enzymes, such as type IV collagenases, as playing a central role in this tumor cell mediated extracellular matrix proteolysis. Two distinct type IV collagenase enzymes are now recognized. Immunohistochemical and biochemical studies of several human tumors show correlations between invasive potential and the 72 kDa type IV collagenase enzyme. Studies in rodent tumor models suggest that the 92 kDa type IV collagenase may play an important role in these models, but data on human tumors and human tumor tissue is lacking. Evidence suggest that the regulation of the 72 kDa type IV collagenase enzyme activity may occur at many levels, including transcriptional mechanisms, extracellular activation of latent enzyme and specific inhibitors of active enzyme. Thus the invasion of human tumor cells through basement membranes may be the result of net type IV collagenolytic activity that is the result of a balance of activated enzyme species and inhibitors.

MeSH Terms
Amino Acid Sequence Animals Base Sequence Humans Matrix Metalloproteinase 9 Microbial Collagenase/physiology Molecular Sequence Data Neoplasm Invasiveness Neoplasm Metastasis/pathology,physiopathology
Chemicals
Microbial Collagenase Matrix Metalloproteinase 9
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Stetler-Stevenson W G
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD.
References (84)
84 references, click to expand
  1. Multilocus molecular mapping of the mouse X chromosome.
    Genomics. 1988 Oct;3(3):187-94 PMID: 2906327
  2. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
    Am J Pathol. 1985 Oct;121(1):1-8 PMID: 3901774
  3. Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid.
    J Biol Chem. 1983 Oct 25;258(20):12259-64 PMID: 6313648
  4. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.
    J Biol Chem. 1988 May 15;263(14):6579-87 PMID: 2834383
  5. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues.
    J Biol Chem. 1990 Aug 15;265(23):13933-8 PMID: 2380196
  6. Tumour basement membrane laminin in adenocarcinoma of rectum: an immunohistochemical study of biological and clinical significance.
    Int J Cancer. 1986 Jun 15;37(6):813-7 PMID: 3519472
  7. Role of oncogenes in metastases.
    Carcinogenesis. 1988 May;9(5):705-10 PMID: 3284663
  8. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue.
    Am J Pathol. 1990 Mar;136(3):585-92 PMID: 2156430
  9. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.
    Cancer Res. 1989 Apr 1;49(7):1698-706 PMID: 2538232
  10. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.
    Proc Natl Acad Sci U S A. 1989 Nov;86(21):8207-11 PMID: 2554304
  11. Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line.
    J Natl Cancer Inst. 1989 Apr 19;81(8):587-94 PMID: 2539488
  12. Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase.
    J Biol Chem. 1984 Aug 10;259(15):9783-9 PMID: 6086649
  13. Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells.
    Proc Natl Acad Sci U S A. 1987 Oct;84(19):6725-9 PMID: 3477804
  14. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells.
    Cancer Res. 1988 Jun 15;48(12):3307-12 PMID: 2836052
  15. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.
    Cancer Res. 1990 Oct 1;50(19):6184-91 PMID: 2169338
  16. Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase.
    J Biol Chem. 1985 Mar 10;260(5):3079-83 PMID: 2982848
  17. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor.
    Proc Natl Acad Sci U S A. 1979 May;76(5):2268-72 PMID: 221920
  18. Conditioned tumorigenicity of activated oncogenes.
    Cancer Res. 1986 Jul;46(7):3211-24 PMID: 3011242
  19. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor.
    J Clin Invest. 1985 Jul;76(1):219-24 PMID: 2991337
  20. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.
    J Biol Chem. 1989 Oct 15;264(29):17213-21 PMID: 2551898
  21. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.
    J Biol Chem. 1989 Oct 15;264(29):17374-8 PMID: 2793861
  22. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.
    Cancer Res. 1988 Oct 1;48(19):5539-45 PMID: 3416307
  23. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors.
    J Biol Chem. 1986 Feb 25;261(6):2814-8 PMID: 3005266
  24. The collagenase gene family in humans consists of at least four members.
    Biochem J. 1988 Jul 1;253(1):187-92 PMID: 2844164
  25. Characterization of the cellular binding site for the urokinase-type plasminogen activator.
    J Biol Chem. 1989 Jan 15;264(2):1180-9 PMID: 2536017
  26. Adhesive and degradative properties of human placental cytotrophoblast cells in vitro.
    J Cell Biol. 1989 Aug;109(2):891-902 PMID: 2474556
  27. Metastatic potential correlates with enzymatic degradation of basement membrane collagen.
    Nature. 1980 Mar 6;284(5751):67-8 PMID: 6243750
  28. Tumor heterogeneity.
    Cancer Res. 1984 Jun;44(6):2259-65 PMID: 6372991
  29. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression.
    Cancer Res. 1987 Mar 15;47(6):1473-87 PMID: 3545445
  30. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.
    Nature. 1985 Nov 7-13;318(6041):66-9 PMID: 3903517
  31. An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases.
    Biochem J. 1981 Apr 1;195(1):167-70 PMID: 6272745
  32. cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases.
    Proc Natl Acad Sci U S A. 1990 Apr;87(7):2800-4 PMID: 2157214
  33. Metastasis suppressor genes.
    J Natl Cancer Inst. 1990 Feb 21;82(4):267-76 PMID: 2405170
  34. Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications.
    Cancer Surv. 1988;7(4):597-629 PMID: 3072068
  35. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases.
    J Biol Chem. 1990 Jul 15;265(20):11421-4 PMID: 2164002
  36. Random and nonrandom processes in metastasis, and metastatic inefficiency.
    Invasion Metastasis. 1983;3(4):193-207 PMID: 6588046
  37. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.
    J Biol Chem. 1989 Jan 25;264(3):1353-6 PMID: 2536363
  38. Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells.
    J Biol Chem. 1989 Oct 15;264(29):17445-53 PMID: 2551903
  39. Zinc coordination, function, and structure of zinc enzymes and other proteins.
    Biochemistry. 1990 Jun 19;29(24):5647-59 PMID: 2200508
  40. Basement membrane collagen: degradation by migrating endothelial cells.
    Science. 1983 Jul 15;221(4607):281-3 PMID: 6190230
  41. Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis.
    Biochem Biophys Res Commun. 1988 Feb 29;151(1):158-62 PMID: 2831877
  42. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.
    Cancer Res. 1987 Mar 15;47(6):1523-8 PMID: 3028610
  43. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor.
    Cancer Res. 1990 Jul 1;50(13):4121-30 PMID: 2162253
  44. Tumor suppressors: recessive mutations that lead to cancer.
    Cell. 1988 Apr 22;53(2):173-4 PMID: 3282673
  45. Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase.
    Arch Biochem Biophys. 1988 Nov 15;267(1):211-6 PMID: 2848449
  46. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells.
    Science. 1989 Feb 17;243(4893):947-50 PMID: 2465572
  47. Metalloproteinases and cancer invasion and metastasis.
    Int J Cancer. 1989 Oct 15;44(4):757-60 PMID: 2793248
  48. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells.
    Cancer Res. 1990 Apr 15;50(8):2322-9 PMID: 2156617
  49. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity.
    Nature. 1985 Jun 27-Jul 3;315(6022):768-71 PMID: 3839290
  50. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.
    Cancer Res. 1987 Sep 15;47(18):4869-76 PMID: 3621180
  51. Purification of a type V collagen degrading metalloproteinase from rabbit alveolar macrophages.
    Coll Relat Res. 1984 Dec;4(6):479-92 PMID: 6098407
  52. A latent Mr 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: a member of the collagenase family of enzymes.
    Cancer Res. 1990 Feb 15;50(4):1113-20 PMID: 2297760
  53. Cancer statistics, 1990.
    CA Cancer J Clin. 1990 Jan-Feb;40(1):9-26 PMID: 2104569
  54. Tissue-type plasminogen activator, a new prognostic marker in breast cancer.
    Cancer Res. 1988 Mar 1;48(5):1348-9 PMID: 3124957
  55. Differential effects of phorbol ester on the in vitro invasiveness of malignant and non-malignant human fibroblast cells.
    J Cell Physiol. 1990 Jan;142(1):55-60 PMID: 2153689
  56. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade.
    Cell. 1986 Nov 21;47(4):487-98 PMID: 3022933
  57. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
    Proc Natl Acad Sci U S A. 1990 Jul;87(14):5578-82 PMID: 2164689
  58. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta.
    J Biol Chem. 1989 Jan 25;264(3):1860-9 PMID: 2536374
  59. The clonal evolution of tumor cell populations.
    Science. 1976 Oct 1;194(4260):23-8 PMID: 959840
  60. Gelatinase (type IV collagenase) immunolocalization in cells and tissues: use of an antiserum to rabbit bone gelatinase that identifies high and low Mr forms.
    J Cell Sci. 1989 Mar;92 ( Pt 3):487-95 PMID: 2556414
  61. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells.
    Cancer Res. 1990 Jul 1;50(13):3872-7 PMID: 2162246
  62. Human skin fibroblast collagenase: interaction with substrate and inhibitor.
    Coll Relat Res. 1985 Mar;5(2):167-79 PMID: 2988853
  63. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.
    J Biol Chem. 1985 Feb 25;260(4):2493-500 PMID: 2982822
  64. K562 cells produce and respond to human erythroid-potentiating activity.
    Blood. 1988 Jun;71(6):1720-5 PMID: 2836003
  65. The basement membrane in pathology.
    Lab Invest. 1983 Jun;48(6):656-77 PMID: 6222217
  66. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells.
    Proc Natl Acad Sci U S A. 1981 Oct;78(10):6226-30 PMID: 6947225
  67. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases.
    J Natl Cancer Inst. 1990 Apr 4;82(7):589-95 PMID: 2156082
  68. Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro.
    J Natl Cancer Inst. 1982 Nov;69(5):1049-54 PMID: 6752521
  69. Antibodies to plasminogen activator inhibit human tumor metastasis.
    Cell. 1983 Dec;35(3 Pt 2):611-9 PMID: 6418388
  70. Structure-function relationships in the collagenase family member transin.
    J Biol Chem. 1988 Aug 25;263(24):11892-9 PMID: 2841336
  71. The approaching era of the tumor suppressor genes.
    Science. 1987 Dec 11;238(4833):1539-45 PMID: 3317834
  72. Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens.
    Biochem J. 1982 Apr 1;203(1):209-21 PMID: 6285893
  73. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor.
    Proc Natl Acad Sci U S A. 1986 Apr;83(8):2407-11 PMID: 3010309
  74. Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells.
    Mol Cell Biol. 1989 May;9(5):2133-41 PMID: 2747645
  75. Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture.
    Am J Pathol. 1984 Dec;117(3):339-48 PMID: 6095669
  76. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells.
    Cancer Res. 1989 Aug 15;49(16):4615-21 PMID: 2545347
  77. Blocking of collagenase secretion by estramustine during in vitro tumor cell invasion.
    Cancer Res. 1988 Nov 15;48(22):6262-71 PMID: 2846150
  78. Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype.
    Biochem Biophys Res Commun. 1988 Aug 15;154(3):832-8 PMID: 3044367
  79. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.
    Proc Natl Acad Sci U S A. 1989 Apr;86(8):2632-6 PMID: 2468156
  80. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.
    J Cell Biol. 1989 Feb;108(2):671-82 PMID: 2465298
  81. Identification of an inhibitor of neovascularization from cartilage.
    Science. 1990 Jun 15;248(4961):1408-10 PMID: 1694043
  82. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.
    J Natl Cancer Inst. 1985 Jul;75(1):99-103 PMID: 2989606
  83. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates.
    J Biol Chem. 1985 Oct 5;260(22):12367-76 PMID: 2995374
  84. A primary genetic map of the pericentromeric region of the human X chromosome.
    Genomics. 1988 May;2(4):294-301 PMID: 2906040
Article Info
Journal
Cancer metastasis reviews
Abbr.
Cancer Metastasis Rev
ISSN
0167-7659
Published
1990-12-00
Pages
289-303
Language
English
Region
Netherlands
NLM ID
8605731
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]